Publications by authors named "Peter Lansberg"

Claim this Profile
B
Bridging the "Know-Do" Gaps in Five Non-Communicable Diseases Using a Common Framework Driven by Implementation Science.
James F Donohue, J Stuart Elborn, Peter Lansberg, Afzal Javed, Solomon Tesfaye

J Healthc Leadersh· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates.
Antoine Rimbert, Hinda Daggag, Peter Lansberg, Adam Buckley, Martijn Viel

Front Genet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries.
Tanaya Bharatan, Ratna Devi, Pai-Hui Huang, Afzal Javed, Barrett Jeffers, Peter Lansberg

J Healthc Leadersh· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins and autoimmunity: State-of-the-art.
Sajad Dehnavi, Nasrollah Sohrabi, Mahvash Sadeghi, Peter Lansberg, Maciej Banach

Pharmacol Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting Flexnerism Via Twitterism: Need for Integrating Social Media Application in Blueprinting Pedagogical Strategies for Undergraduate Medical Education.
Yajnavalka Banerjee, Richa Tambi, Mandana Gholami, Alawi Alsheikh-Ali, Riad Bayoumi, Peter Lansberg

JMIR Med Educ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel 6D-approach to radically transform undergraduate medical education: preliminary reflections from MBRU.
Yajnavalka Banerjee, Aida J Azar, Christopher Tuffnell, Peter J Lansberg, Riad Bayoumi

BMC Med Educ· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonadherence to statins: individualized intervention strategies outside the pill box.
Peter Lansberg, Andre Lee, Zhen-Vin Lee, Kannan Subramaniam, Sajita Setia

Vasc Health Risk Manag· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blending Gagne's Instructional Model with Peyton's Approach to Design an Introductory Bioinformatics Lesson Plan for Medical Students: Proof-of-Concept Study.
Richa Tambi, Riad Bayoumi, Peter Lansberg, Yajnavalka Banerjee

JMIR Med Educ· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles.
Jan W Balder, Jeroen K de Vries, Ilja M Nolte, Peter J Lansberg, Jan A Kuivenhoven

J Clin Lipidol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics, Lifestyle, and Low-Density Lipoprotein Cholesterol in Young and Apparently Healthy Women.
Jan-Willem Balder, Antoine Rimbert, Xiang Zhang, Martijn Viel, Roan Kanninga, Peter Lansberg

Circulation· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.
Bernd Hohenstein, Ulrich Julius, Peter Lansberg, Beate Jaeger, Klaus-Peter Mellwig

Atheroscler Suppl· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.
Peter J Lansberg, Yajnavalka Banerjee

N Engl J Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins.
Dan Atar, Seleen Ong, Peter J Lansberg

Am J Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
Jing Pang, Peter J Lansberg, Gerald F Watts

J Atheroscler Thromb· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch national screening and disease management program for Familial Hypercholesterolemia (FH) - A model for Saudi Arabia?
Joseph G Franke, Peter J Lansberg

J Saudi Heart Assoc· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical review: impact of statin substitution policies on patient outcomes.
Dan Atar, Rafael Carmena, Peter Clemmensen, Annik K-Laflamme, Sven Wassmann, Peter Lansberg

Ann Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic effects of statins and beyond.
Peter Lansberg

Cardiology· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.
Jorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, Joep C Defesche, Dick C G Basart, Peter J Lansberg

BMJ· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing.
Brian Starr, S Gaye Hadfield, Barbara A Hutten, Peter J Lansberg, Trond P Leren

Clin Chem Lab Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial hypercholesterolemia: current treatment and advances in management.
Roeland Huijgen, Maud N Vissers, Joep C Defesche, Peter J Lansberg, John J P Kastelein

Expert Rev Cardiovasc Ther· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing familial hypercholesterolaemia: the relevance of genetic testing.
Emily S van Aalst-Cohen, Angelique C M Jansen, Michael W T Tanck, Joep C Defesche, Mieke D Trip, Peter J Lansberg

Eur Heart J· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced method for the identification of patients with inherited hypercholesterolemia.
Joep C Defesche, Peter J Lansberg, Marina A W Umans-Eckenhausen, John J P Kastelein

Semin Vasc Med· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery.
Don Poldermans, Jeroen J Bax, Miklos D Kertai, Boudewijn Krenning, Cynthia M Westerhout, Peter J Lansberg

Circulation· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of subclinical atherosclerosis: beyond risk factor assessment.
Radjesh J Bisoendial, G Kees Hovingh, Eric de Groot, John J P Kastelein, Peter J Lansberg

Curr Opin Lipidol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis